| Original language | English (US) |
|---|---|
| Pages (from-to) | 1394-1397 |
| Number of pages | 4 |
| Journal | American journal of hematology |
| Volume | 97 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 2022 |
ASJC Scopus subject areas
- Hematology
Tyrosine kinase inhibitors dosing for chronic phase chronic myeloid leukemia: The case for starting low with dasatinib (50 mg/day) and ponatinib (15 mg/day)
Ayalew Tefferi, Kebede H. Begna, Kristen B. McCullough
Research output: Contribution to journal › Editorial › peer-review